Stocks in Focus: Level 3 Communications, Inc. (LVLT), Thermo Fisher Scientific Inc. (TMO), Simon Property Group, Inc. (SPG)

Level 3 Communications, Inc. (LVLT) had a light trading with around 1.68M shares changing hands compared to its three month average trading volume of 2.22M. The stock traded between $57.73 and $58.1 before closing at the price of $57.87 with -0.24% change on the day. The Broomfield Colorado 80021 based company is currently trading 31.49% above its 52 week low of $44.01 and -3.76% below its 52 week high of $60.12. Both the RSI indicator and target price of 44.76 and $62.71 respectively, lead us to believe that it should be put on hold over the coming weeks.

Level 3 Communications, Inc., together with its subsidiaries, operates as a facilities-based provider of a range of integrated communications services. It operates through North America, EMEA, and Latin America segments. The company offers Internet protocol (IP) and data services comprising Internet services, virtual private network, Ethernet, content delivery network, media delivery, Vyvx broadcast, managed, cloud and IT, and cloud connect services, as well as Communications as a Service. It also provides transport and fiber services comprising wavelengths, private lines, transoceanic services, and dark fiber, as well as related professional services; local and enterprise voice services, including Voice over Internet Protocol services and traditional circuit-switch based services; collaboration services, such as audio, Web, and video collaboration services; colocation and data center services comprising cloud, hosting, and application management solutions; and security services for mobile users or remote offices, governance, risk management, and compliance. In addition, the company provides wholesale voice services, including voice termination and toll free services. It primarily serves various types of customers, such as enterprises, content, government, and wholesale. The company was founded in 1884 and is headquartered in Broomfield, Colorado.

Thermo Fisher Scientific Inc. (TMO) continued its upward trend with the stock climbing 0.59% or $0.93 to close the day at $157.28 on light trading volume of 1.43M shares, compared to its three month average trading volume of 2.06M. The Waltham Massachusetts 02451 based company has been outperforming the medical laboratories & research group over the past 52 weeks, with the stock gaining 23.95%, compared to the industry which has advanced 27.16% over the same period. With RSI of 74.16, the stock should still continue to rise and get closer to its one year target estimate of $172.53, making it a hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Simon Property Group, Inc. (SPG) shares were down in last trading by -0.4% to $180.94. It experienced lighter than average volume on day. The stock increased in value by almost 2.03% over the past week and fell -0.71% in the past month. It is currently trading 0.43% above its 50 day moving average and -7.34% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -18.91% decrease in value from its one year high of $229.1. The RSI indicator value of 50.45, lead us to believe that it is a hold for now.

Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, management, and development of properties. It primarily invests in regional malls, premium outlets, mills, and community/lifestyle centers to create its portfolio. Simon Property Group, Inc. was founded in 1960 and is based in Indianapolis, Indiana, with additional office in New York, New York.

 

Momentum Stocks: FleetCor Technologies, Inc. (FLT), Concho Resources Inc. (CXO), Thermo Fisher Scientific Inc. (TMO)

FleetCor Technologies, Inc. (FLT) grew with the stock adding 0.63% or $1.05 to close at $168.91 on active trading volume of 1.52M compared its three months average trading volume of 1.04M. The Norcross Georgia 30092 based company operating under the Business Services industry has been trending up for the last 52 weeks, with the shares price now 48.96% up for the period and up by 19.35% so far this year. With price target of $181.57 and a 50.7% rebound from 52-week low, FleetCor Technologies, Inc. has plenty of upside potential, making it a hold with a view buy.

FleetCor Technologies, Inc. provides fuel cards, commercial payment and data solutions, stored value solutions, and workforce payment products and services. It sells a range of customized fleet and lodging payment programs; and offers card products to purchase fuel, lodging, food, toll, transportation, and related products and services at participating locations. The company also offers telematics solution that allows fleet operators to monitor the capacity utilization and movement of vehicles and drivers; vehicle maintenance services; prepaid fuel and food vouchers, and cards; and workforce payment product related to public transportation and toll vouchers. In addition, it provides proprietary equipment that reduces unauthorized and fraudulent transactions to over-the-road trucking fleets, shipping fleets, and other operators of heavily industrialized equipment, including sea-going vessels, mining equipment, agricultural equipment, and locomotives. Further, the company owns and operates proprietary closed-loop networks, such as fleet card, truck stop and fuel merchant, lodging, fueling, fleet management telematics, fuel and food card, voucher, fuel control, maintenance and repair, toll, and distribution networks through which it electronically connects to merchants, and captures, analyzes, and reports customized information. Additionally, it uses third-party networks to deliver its payment programs and services; and provides a range of services, such as issuing and processing, as well as specialized information services. The company sells its products and services directly to businesses, commercial fleets, retailers, oil companies, petroleum marketers, and government entities in North America, Latin America, Europe, Australia, and New Zealand. It has strategic relationships with oil and leasing companies, petroleum marketers, value-added resellers, and others. FleetCor Technologies, Inc. was founded in 1986 and is headquartered in Norcross, Georgia.

Concho Resources Inc. (CXO) had a active trading with around 1.52M shares changing hands compared to its three month average trading volume of 1.42M. The stock traded between $140.28 and $143.41 before closing at the price of $143.11 with 2.32% change on the day. The Midland Texas 79701 based company is currently trading 77.34% above its 52 week low of $86.63 and -3.01% below its 52 week high of $147.55. Both the RSI indicator and target price of  and $162.23 respectively, lead us to believe that it could rise over the coming weeks.

Concho Resources Inc., an independent oil and natural gas company, engages in the acquisition, development, exploration, and production of oil and natural gas properties in the Unites States. The company’s principal operating areas are located in the Permian Basin of southeast New Mexico and West Texas. As of December 31, 2015, its total estimated proved reserves were 623.5 million barrel of oil equivalent. Concho Resources Inc. was founded in 2006 and is headquartered in Midland, Texas.

Thermo Fisher Scientific Inc. (TMO) saw its value increase by 0.1% as the stock gained $0.15 to finish the day at a closing price of $154.89. The stock was lighter in trading and has fluctuated between $126.42-$160.68 per share for the past year. The shares, which traded within a range of $154.27 to $155.49 during the day, are up by 1.97% in the past three months and down by -1.43% over the past six months. It is currently trading 5.02% above its 20 day moving average and 6.93% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $172.53 a share over the next twelve months. The current relative strength index (RSI) reading is 69.42.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

Stocks Trend Analysis: Monsanto Company (MON), Royal Caribbean Cruises Ltd. (RCL), Thermo Fisher Scientific Inc. (TMO)

Monsanto Company (MON) continued its downward trend with the stock declining -0.21% or $-0.23 to close the day at $107.34 on light trading volume of 1.49M shares, compared to its three month average trading volume of 1.95M. The St. Louis Missouri 63167 based company has been outperforming the agricultural chemicals group over the past 52 weeks, with the stock gaining 19.67%, compared to the industry which has advanced 23.98% over the same period. With RSI of 46.78, the stock should still continue to rise and get closer to its one year target estimate of $120.5, making it a hold for now.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands. It also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, soybean, cotton, and canola crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO brands; Intacta RR2 PRO brand; Bollgard and Bollgard II brands; Roundup Ready, Roundup Ready 2 Yield, and Genuity brands; and Roundup Ready 2 Xtend and Bollgard II XtendFlex brands. This segment also licenses a range of germplasm and trait technologies to large and small seed companies. The Agricultural Productivity segment manufactures and sells herbicides for agricultural, industrial, ornamental, turf, and residential lawn and garden applications for weed control, as well as for control of preemergent annual grass and small seeded broadleaf weeds in corn and other crops under the Roundup and Harness brands. The company markets its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, as well as directly to farmers. Monsanto Company has a collaborative agreement with Novozymes to discover, develop, and produce microbial solutions. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was founded in 2000 and is headquartered in St. Louis, Missouri.

Royal Caribbean Cruises Ltd. (RCL) retreated with the stock falling -0.06% or $-0.06 to close at $94.97 on light trading volume of 1.49M compared its three months average trading volume of 1.85M. The Miami Florida 33132 based company operating under the Resorts & Casinos industry has been trending up for the last 52 weeks, with the shares price now 42.79% up for the period and up by 15.76% so far this year. With price target of $105.41 and a 51.26% rebound from 52-week low, Royal Caribbean Cruises Ltd. has plenty of upside potential, making it a hold with a view buy.

Royal Caribbean Cruises Ltd. operates as a cruise company. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Club Cruises, CDF Croisières de France, and TUI Cruises brand names. The Royal Caribbean International brand provides cruise itineraries ranging from 2 to 24 nights with options for onboard dining, entertainment, and other onboard activities to various destinations. The Celebrity Cruises brand offers cruise itineraries ranging from 2 to 18 nights to various destinations; and operates onboard upscale ships that offer accommodations, fine dining, personalized services, and spa facilities. The Azamara Club Cruises brand offers cruise itineraries ranging from 3 to 20 nights that serve the up-market segment of the North American, the United Kingdom, and Australian markets. The Pullmantur brand provides cruise itineraries ranging from 2 to 15 nights with food and entertainment options for families and couples. The CDF Croisières de France brand offers seasonal itineraries to the Mediterranean, Europe, and Caribbean markets. The TUI Cruises brand provides onboard activities, services, shore excursions, and menu offerings for the German cruise market. As of December 31, 2015, the company operated 44 ships with itineraries ranging from 2 to 24 nights on approximately 490 destinations worldwide. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida.

Thermo Fisher Scientific Inc. (TMO) continued its upward trend with the stock climbing 0.32% or $0.49 to close the day at $153.5 on lower than average trading volume of 1.47M shares, compared to its three month average trading volume of 2.09M. The Waltham Massachusetts 02451 based company has been outperforming the medical laboratories & research companies by 1.16% for last three months and its recent gains have pushed the stock slightly up 8.79% YTD, versus the medical laboratories & research industry which is up 6.74% for the same period. The RSI of 67.79 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

3 Trending Stocks: Thermo Fisher Scientific Inc. (TMO), Biogen Inc. (BIIB), PACCAR Inc (PCAR)

Thermo Fisher Scientific Inc. (TMO) managed to rebound with the stock climbing 0.43% or $0.65 to close the day at $152.08 on light trading volume of 1.61M shares, compared to its three month average trading volume of 2.1M. The Waltham Massachusetts 02451 based company has been outperforming the medical laboratories & research group over the past 52 weeks, with the stock gaining 23.97%, compared to the industry which has advanced 26.18% over the same period. With RSI of 65.03, the stock should still continue to rise and get closer to its one year target estimate of $172.53, making it a hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Biogen Inc. (BIIB) climbed 0.09% during last trading as the stock added $0.24 to finish the day at $264.91 with about 1.61M shares changing hands, compared to its three month average trading volume of 1.84M. The $57.54B market cap company, which fluctuated between $263.18 and $265.73 during the day, currently situated 18.78% above its 52 week low of $223.02 and -20.6% away from its one year high of $333.65. The RSI of 32.67 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company’s Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin’s lymphoma; and Aducanumab and E2609 for Alzheimer’s disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer’s disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company’s Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson’s disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.

PACCAR Inc (PCAR) saw its value decrease by -0.61% as the stock dropped $-0.42 to finish the day at a closing price of $68.07. The stock was lighter in trading and has fluctuated between $47.53-$69.8 per share for the past year. The shares, which traded within a range of $67.57 to $68.57 during the day, are up by 27.37% in the past three months and up by 19.47% over the past six months. It is currently trading 1.7% above its 20 day moving average and 4.04% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $68.25 a share over the next twelve months. The current relative strength index (RSI) reading is 57.44. The technical indicator lead us to believe there will be no major movement any time soon, hold.

PACCAR Inc, together with its subsidiaries, designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks worldwide. It operates in three segments: Truck, Parts, and Financial Services. The Truck segment offers trucks that are used for the over-the-road and off-highway hauling of freight, petroleum, wood products, and construction-related and other materials, as well as manufactures engines. The company sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full service leasing operations under the PacLease trade name. This segment provides equipment financing and administrative support services for its franchisees; retail loans and leasing services for small, medium, and large commercial trucking companies, as well as independent owner/operators and other businesses; and truck inventory financing services to independent dealers. In addition, it offers loans and leases directly to customers for acquisition of trucks and related equipment. The company also manufactures and sells industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.

 

3 Notable Runners: Comerica Incorporated (CMA), Thermo Fisher Scientific Inc. (TMO), Fidelity National Financial, Inc. (FNF)

Comerica Incorporated (CMA) failed to extend gains with the stock declining -1.28% or $-0.87 to close the day at $67.27 on lower than average trading volume of 1.76M shares, compared to its three month average trading volume of 2.15M. The Dallas Texas 75201 based company has been outperforming the money center banks companies by 29.4028% for last three months and its recent gains have offset losses to -1.23% YTD, versus the money center banks industry which is up 5.07% for the same period. The RSI of 47.1 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Comerica Incorporated, through its subsidiaries, provides various financial products and services. It operates through three segments: Business Bank, Retail Bank, and Wealth Management. The Business Bank segment offers various products and services, such as commercial loans and lines of credit, deposits, cash management, capital market products, international trade finance, letters of credit, foreign exchange management services, and loan syndication services to middle market businesses, multinational corporations, and governmental entities. The Retail Bank segment provides small business banking and personal financial services, including consumer lending, consumer deposit gathering, and mortgage loan origination. This segment also offers a range of consumer products consisting of deposit accounts, installment loans, credit cards, student loans, home equity lines of credit, and residential mortgage loans. The Wealth Management segment provides products and services comprising fiduciary services, private banking, retirement services, investment management and advisory services, and investment banking and brokerage services. This segment also sells annuity products, as well as life, disability, and long-term care insurance products. The company operates in Texas, California, and Michigan, as well as in Arizona and Florida, the United States; Canada; and Mexico. Comerica Incorporated was founded in 1849 and is headquartered in Dallas, Texas.

Thermo Fisher Scientific Inc. (TMO) had a light trading with around 1.75M shares changing hands compared to its three month average trading volume of 2.1M. The stock traded between $150.23 and $152.41 before closing at the price of $151.67 with -0.83% change on the day. The Waltham Massachusetts 02451 based company is currently trading 27.18% above its 52 week low of $119.75 and -5.41% below its 52 week high of $160.68. Both the RSI indicator and target price of 65.17 and $171.95 respectively, lead us to believe that it should be put on hold over the coming weeks.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Fidelity National Financial, Inc. (FNF) traded within a range of $35.46 to $36.74 after opening the day at $36.07. The company has seen its stock increase in value by 5.71% so far this year. The stock was up close to 0.84% on light volume in last trading session and closed at $35.9 per share. After the recent gain, the stock is currently holding -5.53% below its 52 week high of $38.5 and 30.43% above its 12-month low of $28.24. The shares are up by over 0.83% in the last three months, and the RSI indicator value of 77.81 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

Fidelity National Financial, Inc., together with its subsidiaries, provides title insurance, and technology and transaction services to the real estate and mortgage industries in the United States. Its Title segment offers title insurance, escrow, and other title related services, including collection and trust activities, trustee sales guarantees, recordings and reconveyances, and home warranty insurance. The company’s Black Knight segment provides technology solutions, such as mortgage processing and workflow management software applications, and origination and default technology; and data and analytics services, including alternative valuation services, real estate and mortgage data, modeling and forecasting, and analytical tools that facilitate and automate various business processes in the life cycle of a mortgage. Its Restaurant Group segment owns, operates, and franchises restaurants comprising O’Charley’s, Ninety Nine Restaurants, Village Inn, Bakers Square, and Legendary Baking concepts, as well as J. Alexander’s. The company also offers information used by title insurance underwriters, title agents, and closing attorneys to underwrite title insurance policies for real property sales and transfer; and offers home inspection and commercial inspection services. Fidelity National Financial, Inc. was founded in 1847 and is headquartered in Jacksonville, Florida.

 

Stocks Highlights: Costco Wholesale Corporation (COST), Automatic Data Processing, Inc. (ADP), Thermo Fisher Scientific Inc. (TMO)

Costco Wholesale Corporation (COST) had a light trading with around 1.8M shares changing hands compared to its three month average trading volume of 2.21M. The stock traded between $162.35 and $164 before closing at the price of $163.95 with 0.43% change on the day. The Issaquah Washington 98027 based company is currently trading 19% above its 52 week low of $138.57 and -3.03% below its 52 week high of $169.59. Both the RSI indicator and target price of 61.7 and $174.8 respectively, lead us to believe that it should be put on hold over the coming weeks.

Costco Wholesale Corporation, together with its subsidiaries, operates membership warehouses. It offers branded and private-label products in a range of merchandise categories. The company provides dry and packaged foods, and groceries; snack foods, candies, alcoholic and nonalcoholic beverages, and cleaning supplies; appliances, electronics, health and beauty aids, hardware, and garden and patio; meat, bakery, deli, and produces; and apparel and small appliances. It also operates gas stations, pharmacies, optical dispensing centers, food courts, and hearing-aid centers; and engages in the travel businesses. In addition, the company provides gold star individual and business membership services. As of August 28, 2016, it operated 715 warehouses, including 501 warehouses in the United States, Washington, District of Columbia, and Puerto Rico; 91 in Canada; 36 in Mexico; 28 in the United Kingdom; 25 in Japan; 12 in Korea; 12 in Taiwan; 8 in Australia; and 2 in Spain. Further, the company sells its products through online. The company was formerly known as Costco Companies, Inc. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington.

Automatic Data Processing, Inc. (ADP) failed to extend gains with the stock declining -0.96% or $-0.98 to close the day at $100.99 on active trading volume of 2.61M shares, compared to its three month average trading volume of 2.09M. The Roseland New Jersey 07068 based company has been outperforming the business software & services group over the past 52 weeks, with the stock gaining 24.7%, compared to the industry which has advanced 19.31% over the same period. With RSI of 44.93, the stock should still continue to rise and get closer to its one year target estimate of $99.69, making it a hold for now.

Automatic Data Processing, Inc., together with its subsidiaries, provides business process outsourcing services worldwide. The company operates through two segments, Employer Services and Professional Employer Organization (PEO) Services. The Employer Services segment offers a range of business outsourcing and technology-enabled human capital management (HCM) solutions, including payroll services, benefits administration services, talent management, human resources management solutions, time and attendance management solutions, insurance services, retirement services, and tax and compliance solutions. This segment’s integrated HCM solutions include RUN Powered by ADP, ADP Workforce Now, ADP Vantage HCM, and ADP GlobalView, which assist employers of all sizes in all stages of the employment cycle from recruitment to retirement; and ADP SmartCompliance and ADP Health Compliance. The PEO Services segment provides a human resources (HR) outsourcing solution through a co-employment model to small and mid-sized businesses. This segment offers ADP TotalSource that provides various HR management services and employee benefits functions, such as HR administration, employee benefits, and employer liability management into a single-source solution. The company was founded in 1949 and is headquartered in Roseland, New Jersey.

Thermo Fisher Scientific Inc. (TMO) shares were up in last trading by 6.35% to $152.39. It experienced higher than average volume on day. The stock increased in value by almost 8.09% over the past week and grew 7.71% in the past month. It is currently trading 6.11% above its 50 day moving average and 2.04% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -4.96% decrease in value from its one year high of $160.68. The RSI indicator value of 68.83, lead us to believe that it is a hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

Stocks in Focus: DENTSPLY SIRONA Inc. (XRAY), E. I. du Pont de Nemours and Company (DD), Thermo Fisher Scientific Inc. (TMO)

DENTSPLY SIRONA Inc. (XRAY) had a active trading with around 2.14M shares changing hands compared to its three month average trading volume of 1.67M. The stock traded between $55.79 and $56.78 before closing at the price of $56.57 with -0.05% change on the day. The York Pennsylvania 17405 based company is currently trading 6.43% above its 52 week low of $53.43 and -13.73% below its 52 week high of $65.83. Both the RSI indicator and target price of 41.66 and $67.17 respectively, lead us to believe that it should be put on hold over the coming weeks.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

  1. I. du Pont de Nemours and Company (DD) failed to extend gains with the stock declining -0.37% or $-0.29 to close the day at $77.7 on light trading volume of 2.11M shares, compared to its three month average trading volume of 2.95M. The company has been outperforming the agricultural chemicals group over the past 52 weeks, with the stock gaining 52.91%, compared to the industry which has advanced 33.69% over the same period. With RSI of 71.25, the stock should still continue to rise and get closer to its one year target estimate of $79.31, making it a hold for now.
  2. I. du Pont de Nemours and Company operates as a science and technology based company. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, rice, seed products, herbicides, fungicides, and insecticides, as well as offers crop protection products, such as weed control, disease control, and insect control products. Its Electronics & Communications segment provides various materials and systems, including photopolymers and electronic materials for photovoltaic, consumer electronics, displays, and advanced printing. The company’s Industrial Biosciences segment develops and manufactures a portfolio of enzymes and bio-based materials. Its Nutrition & Health segment offers cultures, probiotics, texturants, emulsifiers, natural sweeteners, and soy-based food ingredients for the food industry market. The company’s Performance Materials segment offers elastomers and thermoplastic, and thermoset engineering polymers; resins and films for packaging and industrial polymer applications, sealants and adhesives, and sporting goods; and elastomers, parts, and systems and solutions for automotive and transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor, and aerospace markets. Its Safety & Protection segment provides nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The company markets its products through the company’s sales force and distributors in the United States and internationally. E. I. du Pont de Nemours and Company was founded in 1802 and is headquartered in Wilmington, Delaware.

Thermo Fisher Scientific Inc. (TMO) shares were up in last trading by 1.64% to $145.45. It experienced higher than average volume on day. The stock increased in value by almost 1.35% over the past week and grew 2.13% in the past month. It is currently trading 1.17% above its 50 day moving average and -2.6% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -9.29% decrease in value from its one year high of $160.68. The RSI indicator value of 57.16, lead us to believe that it is a hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

Stocks Trending Alert: PACCAR Inc (PCAR), The Kraft Heinz Company (KHC), Thermo Fisher Scientific Inc. (TMO)

PACCAR Inc (PCAR) saw its value increase by 2.55% as the stock gained $1.7 to finish the day at a closing price of $68.4. The stock was higher in trading and has fluctuated between $45.01-$68.69 per share for the past year. The shares, which traded within a range of $66.82 to $68.69 during the day, are up by 22.99% in the past three months and up by 19.22% over the past six months. It is currently trading 3.95% above its 20 day moving average and 6.79% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $66.1 a share over the next twelve months. The current relative strength index (RSI) reading is 64.12.The technical indicator lead us to believe there will be no major movement any time soon, hold.

PACCAR Inc, together with its subsidiaries, designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks worldwide. It operates in three segments: Truck, Parts, and Financial Services. The Truck segment offers trucks that are used for the over-the-road and off-highway hauling of freight, petroleum, wood products, and construction-related and other materials, as well as manufactures engines. The company sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full service leasing operations under the PacLease trade name. This segment provides equipment financing and administrative support services for its franchisees; retail loans and leasing services for small, medium, and large commercial trucking companies, as well as independent owner/operators and other businesses; and truck inventory financing services to independent dealers. In addition, it offers loans and leases directly to customers for acquisition of trucks and related equipment. The company also manufactures and sells industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.

The Kraft Heinz Company (KHC) shares were up in last trading by 0.17% to $88.84. It experienced lighter than average volume on day. The stock increased in value by almost 0.55% over the past week and grew 1.79% in the past month. It is currently trading 4.83% above its 50 day moving average and 4.6% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.17% decrease in value from its one year high of $90.54. The RSI indicator value of 64.71, lead us to believe that it is a hold for now.

The Kraft Heinz Company manufactures and markets food and beverage products in the United States, Canada, Europe, and rest of world. The company’s products include condiments and sauces, cheese and dairy products, meals, meats, refreshment beverages, coffee, snack nuts, dressings, packaged dinners, infant/nutrition products, and other grocery products. It offers its products under various brand names, including Kraft, Oscar Mayer, Heinz, Planters, Velveeta, Philadelphia, Lunchables, Maxwell House, Capri Sun, Ore-Ida, Kool-Aid, Jell-O, Cracker Barrel, Tassimo, Plasmon, Lea & Perrins, ABC, Master, Quero, Golden Circle, Wattie’s, and Complan. The Kraft Heinz Company sells its products through independent brokers, agents and distributors to chain, wholesale, cooperative and independent grocery accounts, convenience stores, drug stores, value stores, bakeries, pharmacies, mass merchants, club stores, hotels, restaurants, hospitals, health care facilities, and certain government agencies, as well as through its own sales organizations. The company was formerly known as H.J. Heinz Holding Corporation and changed its name to The Kraft Heinz Company in July 2015. The Kraft Heinz Company was founded in 2013 and is headquartered in Pittsburgh, Pennsylvania.

Thermo Fisher Scientific Inc. (TMO) traded within a range of $140.77 to $143.02 after opening the day at $141.5. The company has seen its stock increase in value by 0.94% so far this year. The stock was up close to 1.03% on active volume in last trading session and closed at $142.43 per share. After the recent gain, the stock is currently holding -11.18% below its 52 week high of $160.68 and 19.43% above its 12-month low of $119.75. The shares are down by over -6.88% in the last three months, and the RSI indicator value of 44.5 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

Three Movers to Watch for: Thermo Fisher Scientific Inc. (TMO), Sabre Corporation (SABR), Lockheed Martin Corporation (LMT)

Thermo Fisher Scientific Inc. (TMO) retreated with the stock falling -1.27% or $-1.81 to close at $140.98 on light trading volume of 2.99M compared its three months average trading volume of 2M. The Waltham Massachusetts 02451 based company operating under the Medical Laboratories & Research industry has been trending up for the last 52 weeks, with the shares price now 5.07% up for the period and down by -0.09% so far this year. With price target of $172.42 and a 18.22% rebound from 52-week low, Thermo Fisher Scientific Inc. has plenty of upside potential, making it a hold with a view buy.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Sabre Corporation (SABR) dropped $-0.31 to close the day at a new closing price of $24.51, a -1.25% decrease in value from its previous closing price that moved the stock 13.45% above its 52 week low of $22.03. A total of 2.99M shares exchanged hands during the day compared with its three month average trading volume of 2.84M. The stock, which fluctuated between $24.42 and $24.78 during the day, currently situated -16.45% below its 52 week high. The stock is down by -2.54% in the past one month and down by -4.44% over the past three months. With a one year target estimate of $30.91 and RSI of 37.94, the stock still has upside potential, making it a hold for now.

Sabre Corporation provides technology solutions to the travel and tourism industry. The company operates through two segments, Travel Network, and Airline and Hospitality Solutions. The Travel Network segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. The Airline and Hospitality Solutions segment offers a portfolio of software technology products and solutions through software-as-a-service and hosted delivery models to airlines, hotel properties, and other travel suppliers. This segment provides SabreSonic Customer Sales & Service, a reservation system that provides capabilities around managing sales and customer service across an airline’s diverse touch points; Sabre AirVision Marketing & Planning, a set of airline commercial planning solutions; and Sabre AirCentre Enterprise Operations, a set of solutions for the holistic planning and management of airline, airport, and customer operations. In addition, this segment offers software and solutions to hotel properties comprising central reservation system, property management solution, and marketing and consulting services. Sabre Corporation was founded in 2006 and is headquartered in Southlake, Texas.

Lockheed Martin Corporation (LMT) shares were down in last trading by -1.77% to $252.91. It experienced higher than average volume on day. The stock decreased in value by almost -0.48% over the past week and grew 0.15% in the past month. It is currently trading -1.78% below its 50 day moving average and 3.63% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -6.29% decrease in value from its one year high of $269.9. The RSI indicator value of 43.8, lead us to believe that it is a hold for now.

Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services worldwide. Its Aeronautics segment offers combat and air mobility aircraft, unmanned air vehicles, and related technologies. The company’s Information Systems & Global Solutions segment provides technology systems and expertise, integrated information technology solutions, and management services; and supports customers in data analytics, data center operation, and air traffic management. This segment also provides network-enabled situational awareness; integrates complex global systems that help customers to gather, analyze, and distribute critical data; and technical and sustainment services. Its Missiles and Fire Control segment provides air and missile defense systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations and engineering support, readiness, and integration services; manned and unmanned ground vehicles; and energy management solutions. The company’s Rotary and Mission Systems segment offers helicopters; and integrated air and missile defense, littoral warfare, undersea warfare, radar, electronic warfare, cyber solutions, C4ISR systems, and training and logistics systems. Its Space Systems provides satellites, strategic and defensive missile systems, and space transportation systems; and classified systems and services in the support of national security systems. The company serves civil, defense, intelligence, and other government customers. Lockheed Martin Corporation was founded in 1909 and is headquartered in Bethesda, Maryland.

 

Equities Trend Analysis: Thermo Fisher Scientific Inc. (TMO), Abercrombie & Fitch Co. (ANF), The Medicines Company (MDCO)

Thermo Fisher Scientific Inc. (TMO) grew with the stock adding 0.22% or $0.32 to close at $146.29 on light trading volume of 1.84M compared its three months average trading volume of 2.02M. The Waltham Massachusetts 02451 based company operating under the Medical Laboratories & Research industry has been trending up for the last 52 weeks, with the shares price now 8.18% up for the period and up by 3.68% so far this year. With price target of $172.83 and a 22.67% rebound from 52-week low, Thermo Fisher Scientific Inc. has plenty of upside potential, making it a hold with a view buy.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Abercrombie & Fitch Co. (ANF) had a light trading with around 1.84M shares changing hands compared to its three month average trading volume of 3.32M. The stock traded between $11.8 and $12.12 before closing at the price of $11.88 with 0.51% change on the day. The New Albany Ohio 43054 based company is currently trading 3.04% above its 52 week low of $11.53 and -62.55% below its 52 week high of $32.83. Both the RSI indicator and target price of  and $13.85 respectively, lead us to believe that it could rise over the coming weeks.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel. The company sells knit and woven shirts, graphic T-shirts, fleece, jeans and woven pants, shorts, sweaters, and outerwear; personal care products; and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, and Hollister brand names. As of March 2, 2016, it operated through 754 stores in the United States; and 178 stores in Canada, Europe, Asia, and the Middle East. The company sells its products through its stores and direct-to-consumer sales. Abercrombie & Fitch Co. was founded in 1892 and is headquartered in New Albany, Ohio.

The Medicines Company (MDCO) saw its value increase by 4.9% as the stock gained $1.78 to finish the day at a closing price of $38.12. The stock was higher in trading and has fluctuated between $27.5-$41.79 per share for the past year. The shares, which traded within a range of $36.35 to $38.43 during the day, are up by 6.48% in the past three months and up by 5.54% over the past six months. It is currently trading 7.39% above its 20 day moving average and 8.3% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $52.18 a share over the next twelve months. The current relative strength index (RSI) reading is 62.28.The technical indicator lead us to believe there will be no major movement any time soon, hold.

The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. It also markets Kengreal, an intravenous small molecule antiplatelet agent for reducing the risk of periprocedural thrombotic events; Minocin IV, an antibiotic for the treatment of bacterial infections; Orbactiv for the treatment of acute bacterial skin and skin structure infections; and ready-to-use formulation of Argatroban for the treatment of thrombosis, as well as acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases. The company’s products under development also comprise ABP-700, an intravenous anesthetic agent for moderate or deep sedation and general anesthesia in patients undergoing diagnostic or therapeutic procedures; ALN-PCSsc for the treatment of hypercholesterolemia; Carbavance, an antibiotic agent for the treatment of hospitalized patients with gram-negative bacterial infections; and MDCO-216, a novel biologic product to reverse atherosclerotic plaque development and reduce the risk of ischemic events in patients with ACS. It has a collaboration agreement with Alnylam Pharmaceuticals, Inc,; SciClone Pharmaceuticals; and SymBio Pharmaceuticals Ltd. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.